(Q43596359)

25 November 2017

title

M100907, a selective 5-HT(2A) receptor antagonist, attenuates phencyclidine-induced Fos expression in discrete regions of rat brain (English)

1 reference

25 November 2017

T Habara

1

1 reference

25 November 2017

T Hamamura

2

1 reference

25 November 2017

M Miki

3

1 reference

25 November 2017

K Ohashi

4

1 reference

25 November 2017

S Kuroda

5

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

European Journal of Pharmacology

25 November 2017

published in

1 reference

25 November 2017

volume

417

1 reference

25 November 2017

issue

3

1 reference

25 November 2017

page(s)

189-194

1 reference

Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine.

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900926-8

Phencyclidine-induced psychosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900926-8

Clozapine. A novel antipsychotic agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900926-8

Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900926-8

Cellular and subcellular distribution of the serotonin 5-HT2A receptor in the central nervous system of adult rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900926-8

The effects of antipsychotic drugs on Fos protein expression in the prefrontal cortex: cellular localization and pharmacological characterization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900926-8

The use of c-fos as a metabolic marker in neuronal pathway tracing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900926-8

Effects of neuroleptics on phencyclidine (PCP)-induced locomotor stimulation in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900926-8

Phencyclidine-induced locomotor activity in the rat is blocked by 6-hydroxydopamine lesion of the nucleus accumbens: Comparisons to other psychomotor stimulants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900926-8

Phencyclidine binding sites in the nucleus accumbens and phencyclidine-induced hyperactivity are decreased following lesions of the mesolimbic dopamine system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900926-8

Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900926-8

Phencyclidine (PCP) injected in the nucleus accumbens increases extracellular dopamine and serotonin as measured by microdialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900926-8

Effect of phencyclidine on dopamine release in the rat prefrontal cortex; an in vivo microdialysis study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900926-8

Recent advances in the phencyclidine model of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900926-8

Blockade of phencyclidine-induced hyperlocomotion by clozapine and MDL 100,907 in rats reflects antagonism of 5-HT2A receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900926-8

Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900926-8

The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900926-8

Contrasting mechanisms of action and sensitivity to antipsychotics of phencyclidine versus amphetamine: importance of nucleus accumbens 5-HT2Asites for PCP-induced locomotion in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900926-8

Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900926-8

Reversal of amphetamine-induced behaviours by MDL 100,907, a selective 5-HT2A antagonist.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900926-8

Effects of phencyclidine on immediate early gene expression in the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900926-8

5-HT2 receptor antagonism reduces hyperactivity induced by amphetamine, cocaine, and MK-801 but not D1 agonist C-APB

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900926-8

Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900926-8

Expression of c-fos protein in brain: metabolic mapping at the cellular level

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900926-8

Developmental changes in distribution patterns of phencyclidine-induced c-Fos in rat forebrain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900926-8

The preferential dopamine D3 receptor agonist cis-8-OH-PBZI induces limbic Fos expression in rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900926-8

5-HT2 receptors exert a state-dependent regulation of dopaminergic function: studies with MDL 100,907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900926-8

Phencyclidine (PCP) acts at sigma sites to induce c-fos gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900926-8

The glucose oxidase-DAB-nickel method in peroxidase histochemistry of the nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900926-8

The behavioral and neurochemical effects of phencyclidine in humans and animals: some implications for modeling psychosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900926-8

The role of nucleus accumbens dopamine in the neurochemical and behavioral effects of phencyclidine: a microdialysis and behavioral study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900926-8

Phencyclidine increases extracellular dopamine metabolites in rat medial frontal cortex as measured by in vivo dialysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900926-8

Involvement of dopamine D1 receptors in phencyclidine-induced behavioral stimulation in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900926-8

Acute administration of typical and atypical antipsychotic drugs induces distinctive patterns of Fos expression in the rat forebrain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900926-8

10.1016/S0014-2999(01)00926-8

7 January 2021

Identifiers

DOI

1 reference

25 November 2017

1 reference